Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI

Launched by PEKING UNIVERSITY FIRST HOSPITAL · Mar 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two different devices used to stop bleeding from the radial artery after procedures called coronary angiography (CAG) or percutaneous coronary intervention (PCI). One group of participants will use a new device that applies pressure to help the artery heal, while the other group will use a standard device without pressure monitoring. The main goal is to see if the new device reduces the chances of blood clots or blockages in the artery within 24 hours after the procedure.

To participate, you should be between 18 and 80 years old, undergoing CAG or PCI through the radial artery, and able to pass a simple test that checks blood flow in your hand. If you have certain health issues, like severe kidney disease or liver disease, you may not be eligible. Participants will be monitored for various outcomes, including how quickly bleeding stops and any complications like pain or swelling. This study is currently recruiting participants, so if you think you might be eligible and are interested, you can find out more about joining.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing coronary angiography or percutaneous coronary intervention via the radial artery; Positive Allen's test result; Willing to sign informed consent.
• Exclusion Criteria:
• • Radial artery malformation； Chronic kidney disease with eGFR\<30ml/min.1.73m2; Cirrhosis of the liver; Coagulation disfunction; Patients treated with IIb / IIIa receptor antagonist.